45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Timothy Gilliam, B.S.

B.S.
University of North Carolina at Chapel Hill
101 Manning Dr.
Chapel Hill, NC
USA 27599

Papers:
276 - Poster Session A The HMG-CoA reductase inhibitor simvastatin exhibits antitumorigenic and antimetastatic effects in ovarian cancer 277 - Poster Session A Simvastatin, an HMG-CoA reductase inhibitor, exhibits antimetastatic and antitumorigenic effects in endometrial cancer